HOME > Articles >

Korean J Gastroenterol  <  Volume 74(2); 2019 <  Articles

Korean J Gastroenterol 2019; 74(2): 101-109  https://doi.org/10.4166/kjg.2019.74.2.101
2018 Korean Liver Cancer Association and National Cancer Center for Clinical Practice Guidelines of Hepatocellular Carcinoma: What’s Different from 2014?
Ji Hoon Kim
Department of Internal Medicine, Korea University Guro Hospital, Seoul, Korea
Correspondence to: Ji Hoon Kim, Department of Internal Medicine, Korea University Guro Hospital, 148 Gurodong-ro, Guro-gu, Seoul 08308, Korea. Tel: +82-2-2626-3011, Fax: +82-2-2626-1038, E-mail: kjhhepar@naver.com, ORCID: https://orcid.org/0000-0003-3924-0434
Received: April 16, 2019; Revised: August 18, 2019; Accepted: August 18, 2019; Published online: August 25, 2019.
© The Korean Journal of Gastroenterology. All rights reserved.

This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
The Korean clinical practice guidelines for the management of hepatocellular carcinoma (HCC) was originally enacted in 2004 by the Korean Liver Cancer Association (KLCA)-National Cancer Center (NCC) Korea in order to provide medical practitioners with specific medical information regarding HCC to help them facilitate their understanding of the disease and treatment of the patients. KLCA-NCC Korea practice guidelines for the management of HCC have been revised entirely two times in 2009, and 2014. Although several major international liver association have established and revised clinical practice guidelines, since the medical environment in each country is somewhat different depending on race, region, institution, and economic conditions, it is necessary to revise the Korean guidelines to that reflect our medical environments and own research results. In this review, major change and its background will be summarized about 2018 updated clinical practice guidelines for the management of HCC.
Keywords: Carcinoma, hepatocellular; Guideline; Therapeutics

This Article

Author ORCID Information

Stats or Metrics
  • View: 181
  • Download: 161

Social Network Service



Official Journal of

Indexed/Covered by

  • thomson reuters
  • pubmedcentral
  • koreamed
  • crossref
  • crossref
  • synepse
  • kofst
  • DOAJ